Mirae Asset Global Investments
PRAX icon

Mirae Asset Global Investments’s Praxis Precision Medicines PRAX Stock Holding History

Mirae Asset Global Investments’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$417K Sell
1,247
-206
-14% -$65.2K ﹤0.01% 1013
2026
Q1 		$468K Buy
1,453
+238
+20% +$73.6K ﹤0.01% 948
2025
Q4 		$358K Buy
1,215
+401
+49% +$74.7K ﹤0.01% 1056
2025
Q3 		$43.1K Buy
814
+27
+3% +$1.31K ﹤0.01% 1374
2025
Q2 		$33.1K Buy
787
+112
+17% +$4.26K ﹤0.01% 1317
2025
Q1 		$26.1K Buy
675
+54
+9% +$3.37K ﹤0.01% 1355
2024
Q4 		$47.8K Buy
+621
New +$44.9K ﹤0.01% 1271

Other funds holding PRAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM

Mirae Asset Global Investments's PRAX Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Praxis Precision Medicines (PRAX) stake by 14% in Q2 2026, selling an estimated $65.2K and leaving 1,247 shares worth $417K. The position accounts for ﹤0.01% of the portfolio, ranked #1013.

Mirae Asset Global Investments first reported a position in PRAX in Q4 2024 and has held it in 7 quarters since. The position peaked at $468K in Q1 2026. 93 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Mirae Asset Global Investments held 1,247 shares of Praxis Precision Medicines worth $417K as of Q2 2026.
  • Mirae Asset Global Investments sold 206 Praxis Precision Medicines shares in Q2 2026, an estimated $65.2K.
  • Praxis Precision Medicines made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1013 holding.
  • Mirae Asset Global Investments first reported a position in Praxis Precision Medicines in Q4 2024 and has held it in 7 quarters since.
  • Mirae Asset Global Investments's Praxis Precision Medicines position peaked at $468K in Q1 2026.
  • 93 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.